The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Similar stories
5 outlets
See how this story developed, hour by hour
‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows
theguardian.com
23.10.2026
Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial
nbcnews.com
23.10.2026
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
nytimes.com
22.10.2026
A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
time.com
23.10.2026
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
arstechnica.com
23.10.2026
Related stories
My 93-year-old mother waited 10 hours on the floor for an ambulance
'My Workouts Stopped Working in Midlife. These 8 Lessons Helped Me Get Back on Track'
The Unexpected ‘Nobody Wants This’ Season 3 Ending, Explained
Your Horoscope for the Full Moon in Taurus
Sarah J. Maas Books in Order of How to Read Them: An Opinionated Editor’s Guide
How to Style a Vest With All the Fall 2026 Trends, From Regencycore to Horse-Girl Style